News
Billy Evans, who is the partner of Theranos founder Elizabeth Holmes has started a new blood-testing company, Haemanthus.
Most human diseases are complicated, and we usually need comprehensive testing approaches to diagnose them. Relying only on ...
Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 billion, including $200 million upfront. GSK is paying $1.2 billion upfront ...
The partner of former Theranos founder and chief executive Elizabeth Holmes, Billy Evans, has reportedly raised millions of ...
Clinicians can detect many conditions with blood, and some with urine or saliva. The volumes required are usually much ...
Theranos, a biotech company, once promised a revolution in blood diagnostics with its innovative technology. Despite vast ...
Biotech startup Haemanthus says it can detect illnesses with tiny amounts of blood, urine and saliva. Here’s why that’s more difficult than it sounds.
In the 2000s, biotech company Theranos promised to revolutionize blood testing. Founder Elizabeth Holmes claimed Theranos ...
A startup with Theranos ties has another blood test in the works. This time, competition is waiting.
A stealth startup built by the partner of disgraced Theranos founder Elizabeth Holmes is taking a shot at a new blood test — ...
Elizabeth Holmes had more resources, talent, and opportunity than most founders will ever see — and she blew it. Now, writes Theranos whistleblower Tyler Shultz, she seems to be trying again.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results